Supernus Pharmaceuticals Total Assets 2011-2024 | SUPN

Supernus Pharmaceuticals total assets from 2011 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Supernus Pharmaceuticals Annual Total Assets
(Millions of US $)
2023 $1,278
2022 $1,703
2021 $1,689
2020 $1,504
2019 $1,160
2018 $978
2017 $424
2016 $310
2015 $189
2014 $137
2013 $111
2012 $94
2011 $54
2010 $0
Supernus Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2024-06-30 $1,316
2024-03-31 $1,304
2023-12-31 $1,278
2023-09-30 $1,285
2023-06-30 $1,293
2023-03-31 $1,792
2022-12-31 $1,703
2022-09-30 $1,693
2022-06-30 $1,695
2022-03-31 $1,640
2021-12-31 $1,689
2021-09-30 $1,555
2021-06-30 $1,573
2021-03-31 $1,507
2020-12-31 $1,504
2020-09-30 $1,510
2020-06-30 $1,491
2020-03-31 $1,190
2019-12-31 $1,160
2019-09-30 $1,107
2019-06-30 $1,064
2019-03-31 $1,025
2018-12-31 $978
2018-09-30 $923
2018-06-30 $853
2018-03-31 $825
2017-12-31 $424
2017-09-30 $385
2017-06-30 $346
2017-03-31 $322
2016-12-31 $310
2016-09-30 $285
2016-06-30 $219
2016-03-31 $194
2015-12-31 $189
2015-09-30 $167
2015-06-30 $154
2015-03-31 $139
2014-12-31 $137
2014-09-30 $126
2014-06-30 $94
2014-03-31 $98
2013-12-31 $111
2013-09-30 $124
2013-06-30 $132
2013-03-31 $79
2012-12-31 $94
2012-09-30 $67
2012-06-30 $80
2012-03-31 $43
2011-12-31 $54
2011-09-30 $0
2011-06-30 $0
2011-03-31 $0
2010-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $1.872B $0.608B
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00